DECEMBER 2023LIFE SCIENCES REVIEW3For more information, connect with us.© 2021 Coriell Life Sciences · www.coriell.com · (888) 415-7834 · info@coriell.com · @CorielllifeVirtual Medication Safety ProgramThe Power to Improve Lives, Reduce Costs, and Simplify Decision-MakingA Case Study in Smarter Health Care· Average savings: $5,176 per enrollee.*· Non-enrollee costs grew 12% faster than those in the Program.*· 11% reduction in pharmacy spend.· 22% reduction in hospitalizations.· 27% reduction in slips-and-falls.Better Health Through Personalized MedicineBeginning with an ROI analysis, our turnkey, population-scale Medication Safety Program delivers measurable results for Employers, Health Plans, Pharmacy Benefits Managers, and other large populations. The Corigen Program progresses from member outreach and at-home enrollment to genetic testing, ending with medication therapy management with communication to each participating members' prescribing physician.Member EngagementFully coordinated education and enrollmentGenetic TestingCost-effective, comprehensive DNA testing by CLIA-licensed laboratoriesPharmacy MTM ReviewRecommendations of medications to add, remove, change dosing, and keep the sameCorigen® ProgramCoriell Life SciencesIf you were taking a medication that wasn't effective, wouldn't you want to know? Now more than ever, especially with the need for immediate and better mental health treatment, it's important for individuals to learn about the power of precision medicine. Coriell Life Sciences' Corigen Program:Enables appropriate prescribing decisions in accordance with individual genetics in addition to many other personal variables.Empowers healthcare providers with informed answers rather than more research materials and confusing reports.Provides real-time regimen modeling that allows pharmacists and doctors to see the impact of medication changes, eliminating trial-and-error guesswork and auditioning of drugs that could be ineffective or even harmful.Population AnalyticsProprietary risk analysis system reveals "high risk, likely-to-benefit" members* Based on charged amount at an 18 month review, validated by Aon.
< Page 2 | Page 4 >